PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease

P Ge, VL Dawson, TM Dawson - Molecular neurodegeneration, 2020 - Springer
That certain cell types in the central nervous system are more likely to undergo
neurodegeneration in Parkinson's disease is a widely appreciated but poorly understood …

Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery

UB Pandey, CD Nichols, EL Barker - Pharmacological reviews, 2011 - Elsevier
The common fruit fly, Drosophila melanogaster, is a well studied and highly tractable genetic
model organism for understanding molecular mechanisms of human diseases. Many basic …

[HTML][HTML] α-Synuclein misfolding and Parkinson's disease

L Breydo, JW Wu, VN Uversky - … et Biophysica Acta (BBA)-Molecular Basis …, 2012 - Elsevier
Substantial evidence links α-synuclein, a small highly conserved presynaptic protein with
unknown function, to both familial and sporadic Parkinson's disease (PD). α-Synuclein has …

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

S Duty, P Jenner - British journal of pharmacology, 2011 - Wiley Online Library
Animal models of Parkinson's disease (PD) have proved highly effective in the discovery of
novel treatments for motor symptoms of PD and in the search for clues to the underlying …

What genetics tells us about the causes and mechanisms of Parkinson's disease

O Corti, S Lesage, A Brice - Physiological reviews, 2011 - journals.physiology.org
Parkinson's disease (PD) is a common motor disorder of mysterious etiology. It is due to the
progressive degeneration of the dopaminergic neurons of the substantia nigra and is …

Drosophila, the golden bug, emerges as a tool for human genetics

E Bier - Nature Reviews Genetics, 2005 - nature.com
Drosophila melanogaster is emerging as one of the most effective tools for analyzing the
function of human disease genes, including those responsible for developmental and …

Drug discovery in the ubiquitin–proteasome system

G Nalepa, M Rolfe, JW Harper - Nature reviews Drug discovery, 2006 - nature.com
Regulated protein turnover via the ubiquitin–proteasome system (UPS) underlies a wide
variety of signalling pathways, from cell-cycle control and transcription to development …

Role of post-translational modifications in modulating the structure, function and toxicity of α-synuclein: implications for Parkinson's disease pathogenesis and …

A Oueslati, M Fournier, HA Lashuel - Progress in brain research, 2010 - Elsevier
A better understanding of the molecular and cellular determinants that influence the
pathology of Parkinson's disease (PD) is essential for developing effective diagnostic …

Neuroprotective and therapeutic strategies against Parkinson's disease: recent perspectives

S Sarkar, J Raymick, S Imam - International journal of molecular sciences, 2016 - mdpi.com
Parkinsonism is a progressive motor disease that affects 1.5 million Americans and is the
second most common neurodegenerative disease after Alzheimer's. Typical …

The biochemistry of Parkinson's disease

MR Cookson - Annu. Rev. Biochem., 2005 - annualreviews.org
▪ Abstract Several genes have been identified for monogenic disorders that variably
resemble Parkinson's disease. Dominant mutations in the gene encoding α-synuclein …